Pharmafile Logo

News and Press Releases

Travere Therapeutics to Present at Upcoming Investor Conferences

4 November 2024 -- California, US -- Travere Therapeutics, Inc today announced that company management will present in the following upcoming investor conferences in November: Guggenheim Securities Healthcare Innovation ConferenceMonday, November 11,...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: November 4, 2024

Travere Therapeutics
3611 Valley Centre Drive, Suite 300 San Diego, CA 92130

53Biologics Awarded Best Company in Biotechnology Innovation at Farmaforum

This award acknowledges the company’s groundbreaking work in microbial expression systems and its ongoing commitment to delivering cutting-edge biotechnological solutions for the global market. 53Biologics, a Contract Development and Manufacturing...

Category: Biotechnology
Posted: October 30, 2024

53Biologics
info@53biologics.com
13th Louis Proust Street, 47151, Valladolid, Spain

Chiesi Group’s new Biotech Center of Excellence brings the future of medicine to Parma

Chiesi Group is making a strategic investment of €400 million to establish its new Biotech Center of Excellence in Parma The Center is designed to integrate the entire supply chain,...

Category: Biotechnology
Posted: October 24, 2024

Chiesi
info@chiesi.uk.com
333 Styal Road Manchester M22 5LG United Kingdom

Biotech Capital on the Rise and Outsourcing to Accelerate in 2025 – but Uneven Growth for CDMOs

European Biotech Recovery Gains Momentum as Chinese Biotech Declines, and IPO Activity Remains Weak New research launched at CPHI Milan – the world’s largest pharma event, held at Fiera Milano...

Category: Pharmaceutical
Posted: October 11, 2024

CPHI
5 Howick Place, London SW1P 1WG

AzurBio Pharma Launches to Fast-Track European Market Entry for Biopharma Companies with Breakthrough Treatments

1 October 2024 -- Paris, France -- AzurBio Pharma, specializing in bringing innovative pharmaceutical products to European markets and focusing on rare and serious diseases with unmet medical needs, is...

Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: October 1, 2024

AzurBio Pharma
32 Av. Kléber, 75116 Paris, France

Successful Conclusion of London Biotechnology Show, Leaves Attendees Highly Satisfied

10 May 2024 -- London, UK -- The curtain has closed on the debut London Biotechnology Show 2024, leaving attendees thoroughly impressed by the seamless delivery of promised content and...

Category: Biotechnology
Posted: May 10, 2024

London Biotechnology Show
info@londonbiotechshow.com

One2Treat launches ground-breaking treatment-decision approach to clinical research and market access analysis

One2Treat reflects patient priorities in a single comprehensive treatment evaluation, reducing trial sample size and accelerating patient access to new treatments 26 March 2024 -- Brussels, Belgium -- One2Treat, a...

Category: Clinical Trials, Pharmaceutical
Posted: March 26, 2024

One2Treat
info@one2treat.com
Rue Emile Francqui, 1-1435 Mont-Saint-Guibert, Belgium

Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication

 Next-generation suite enhances research productivity and innovation across chemical, pharmaceutical and biotechnology industries and academia Seamless integration within Revvity Signals Research platform empowers multidisciplinary discoveries. 18 March 2024 -- Massachusetts,...

Category: Biotechnology
Posted: March 18, 2024

Revvity
Ruixin.Zhu@revvity.com
940 Winter St, Waltham, MA, United States

Phesi launches Health Check and Trial Rescue Service to save at-risk trials and bring drugs to market faster

New free of charge service will offer insights in under ten days to sponsors conducting clinical trials in any indication, identifying potential “zombie trials” and providing actionable recommendations for failing...

Category: Pharmaceutical
Posted: October 12, 2023

Phesi
info@phesi.com
East Lyme, Connecticut, US